For the Inventor, By the Inventor

Enter assignee name

South San Francisco, CA, United States of America

Gryphon Therapeutics, Inc.

USPTO Granted Patents = 9

Forward Citations = 160

Loading Chart...

Loading Chart...

15 inventors (with patents filed for the assignee):

Stephen B H Kent (5 out of 21 patents)

Reyna J Simon (3 out of 11 patents)

Keith Rose (3 out of 11 patents)

4. Robin E Offord (3 out of 13 patents)

5. Paolo Botti (2 out of 11 patents)

6. James A Bradburne (2 out of 3 patents)

7. Lynne Canne (2 out of 3 patents)

8. Jill Wilken (2 out of 3 patents)

9. Christie L Hunter (1 out of 7 patents)

10. Shiah-yun Chen (1 out of 3 patents)

11. Gerd G Kochendoerfer (1 out of 4 patents)

12. Sonya Cressman (1 out of 2 patents)

13. Donald W Low (1 out of 2 patents)

14. Darren Thompson (1 out of 2 patents)

15. Michael A Siani (1 out of 6 patents)

9 patents: Sort by Forward Citations

1. 7094871 - Solid phase native chemical ligation of unprotected or N-terminal cysteine protected peptides in aqueous solution (2006-08-22),

2. 7030218 - Pseudo native chemical ligation (2006-04-18),

3. 7030217 - Solid phase native chemical ligation of unprotected or N-terminal cysteine protected peptides in aqueous solution (2006-04-18),

4. 6977292 - Nucleophile-stable thioester generating compounds, methods of production and use (2005-12-20),

5. 6942852 - N-terminal modifications of RANTES and methods of use (2005-09-13),

6. 6844161 - Modular protein libraries and methods of preparation (2005-01-18),

7. 6673347 - Polypeptide and protein derivatives and process for their preparation (2004-01-06),

8. 6663869 - Polyoxime compounds and their preparation (2003-12-16),

9. 6552167 - Polyamide chains of precise length (2003-04-22),

Gryphon Therapeutics, Inc. is a biotechnology company dedicated to developing innovative cancer therapies. Our focus lies in leveraging immuno-oncology and precision medicine to create targeted treatments for patients in need. With a team of experienced scientists and clinicians, we are committed to advancing the field of oncology and improving outcomes for cancer patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

9 Patents

#105 in South San Francisco, CA

#7,492 in California

#31,603 in US

South San Francisco, CA, United States of America

Gryphon Therapeutics, Inc.

Forward Citations = 160

15 inventors:

Stephen B H Kent (5 out of 21 patents)

Reyna J Simon (3 out of 11 patents)

Keith Rose (3 out of 11 patents)

4. Robin E Offord (3 out of 13 patents)

5. Paolo Botti (2 out of 11 patents)

Please report any incorrect information to support@idiyas.com

Loading…